X

Dishman Carbogen Amcis Ltd Q1FY25; 28% fall in Revenue

Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.

Financial Results:

Dishman Carbogen Amcis Ltd reported Revenues for Q1FY25 of ₹524.00 Crores down from ₹723.00 Crore year on year, a fall of 27.52%.

Total Expenses for Q1FY25 of ₹598.00 Crores down from ₹700.00 Crores year on year, a fall of 14.57%.

Consolidated Net Profit of -₹78.00 Crores from ₹17.00 Crores in the same quarter of the previous year.

The Earnings per Share is -₹4.95, from ₹1.08 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post